3 Reason's Herbalife Ltd.'s Stock Could Rise

Herbalife shares could be poised for a rally if any of these three things occur.

Aug 19, 2014 at 9:35AM

Under siege from activist hedge fund manager Bill Ackman, multi-level marketing giant Herbalife (NYSE:HLF) has been an immensely volatile stock over the last two years. Ackman's periodic accusations of fraud have, from time to time, sent Herbalife cratering, while strong earnings reports and analyst notes have occasionally buoyed shares.

Although Ackman insists that the company is destined to collapse, other investors are more bullish. Below I offer three reasons as to why Herbalife shares could rally. Of course, it's important to note that even if all possibilities break Herbalife's way, there's no guarantee that the stock will rise. A more general stock market downturn, other threats to the business, or just plain random chance could keep things from turning out well for Herbalife investors. With that in mind, let's get started.

Herbalife is hit with only modest infractions -- or even none
Ackman's ongoing crusade against Herbalife has drawn the attention of several government regulators, most notably the Federal Trade Commission. The FTC has a track record of bringing down pyramid schemes masquerading as legitimate multi-level marketing firms, including Fortune Hi-Tech Marketing and BurnLounge.

Herbalife could be the next firm to fall victim to the FTC's wrath, or at least, that's what Herbalife bears are betting on. If the FTC does charge Herbalife's management with operating an illegal pyramid scheme, the resulting impact on shares is likely to be catastrophic.

However, the inverse is equally true. That is to say, if the FTC were to conclude its formal inquiry with only modest action -- perhaps a small fine or slap on the wrist -- or even none, Herbalife shares could surge to the upside, as the likelihood of a government seizure or shutdown evaporates. Herbalife could continue to operate its business, and though its results could be dampened by any FTC action, the threat of a looming binary event would effectively vanish.

More bullish would be the FTC ending its formal inquiry and taking no action whatsoever. Although other government agencies (including the SEC, several state attorneys general, and perhaps the FBI) are also looking into Herbalife, the FTC has a history of leading the charge when it comes to prosecuting pyramid schemes.

If the FTC found Herbalife to be operating within the limits of the law, the bear case would effectively vanish. The ongoing regulatory threat would dissipate, and Herbalife shares would likely be revalued, gaining a multiple commensurate with the broader market.

A short squeeze is triggered in Herbalife shares
That surge to the upside could be prompted, partly, by a wave of investors rushing to purchase shares of an extraordinarily cheap stock (currently trading with a price-to-earnings ratio near 11). But more significant could be the buying by those investors who had been short shares of Herbalife.

As of this writing, about one-third of Herbalife's outstanding shares have been bet against -- making it one of the most heavily shorted stocks in the market. To stop potentially unlimited losses, short sellers could turn into buyers if Herbalife shares begin to move to the upside.

Even if the FTC's ongoing investigation is not resolved, a short squeeze could still occur. Herbalife's management has undertaken a strategy that has seen it aggressively repurchase its own shares this year. In February, it issued $1 billion in convertible senior notes to expand its buyback program, and in April, it stopped paying a dividend in order to finance more share repurchases. As my Foolish colleague Jim Royal points out, borrowing additional money to buy back even more stock could raise the short interest to untenable levels, prompting a major short squeeze on the slightest positive headline.

Herbalife's rapid growth could resume
The possibility of regulatory action (or inaction) is likely to dominate the Herbalife trade in the near-term. Yet, operational improvements could have a modestly positive affect on Herbalife shares.

Last month, Herbalife disappointed shareholders when it delivered an earnings report that came in short of analysts' expectations. Although Herbalife's adjusted EPS increased 10% from the same period last year, analysts had been expecting better results. Not surprisingly, Herbalife shares declined on the report.

A reversal in fortune, and a string of strong earnings reports could produce the opposite effect. Assuming that Herbalife is, as it says, not a fraudulent company, the market for its weight-loss shakes appears to be expanding. Earlier this year, researchers found that worldwide obesity rates had risen sharply over the last three decades: In the U.S., as many as a third of the population is now obese, and Australia and the U.K. are not far behind.

A special situation
Still, unlike other stocks, which may move on the basis of the underlying company's ability to bring desired products to market, Herbalife is truly a special situation.

At least in the near term, the return on Herbalife shares is likely to be related more to the outcome of ongoing investigations than the business itself. For Herbalife shares to head higher, investors should look for the FTC to end its inquiry with only modest penalties (or no penalties whatsoever). That, in turn, could prompt a short squeeze, and send shares trading significantly higher.

Leaked: This coming blockbuster will make every biotech jealous
The best biotech investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. Let me cut right to the chase. There is a product in development that will revolutionize not just how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. In order to outsmart Wall Street and realize multi-bagger returns you will need The Motley Fool's new free report on the dream-team responsible for this game-changing blockbuster. CLICK HERE NOW.

Sam Mattera owns put options on Herbalife. The Motley Fool has the following options: long January 2016 $57 calls on Herbalife. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Money to your ears - A great FREE investing resource for you

The best way to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as “binge-worthy finance.”

Feb 1, 2016 at 5:03PM

Whether we're in the midst of earnings season or riding out the market's lulls, you want to know the best strategies for your money.

And you'll want to go beyond the hype of screaming TV personalities, fear-mongering ads, and "analysis" from people who might have your email address ... but no track record of success.

In short, you want a voice of reason you can count on.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich," rated The Motley Fool as the #1 place online to get smarter about investing.

And one of the easiest, most enjoyable, most valuable ways to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as "binge-worthy finance."

Whether you make it part of your daily commute or you save up and listen to a handful of episodes for your 50-mile bike rides or long soaks in a bubble bath (or both!), the podcasts make sense of your money.

And unlike so many who want to make the subjects of personal finance and investing complicated and scary, our podcasts are clear, insightful, and (yes, it's true) fun.

Our free suite of podcasts

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. The show is also heard weekly on dozens of radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable. Rule Breaker Investing and Answers are timeless, so it's worth going back to and listening from the very start; the other three are focused more on today's events, so listen to the most recent first.

All are available for free at www.fool.com/podcasts.

If you're looking for a friendly voice ... with great advice on how to make the most of your money ... from a business with a lengthy track record of success ... in clear, compelling language ... I encourage you to give a listen to our free podcasts.

Head to www.fool.com/podcasts, give them a spin, and you can subscribe there (at iTunes, Stitcher, or our other partners) if you want to receive them regularly.

It's money to your ears.

 


Compare Brokers